Attend the world’s most comprehensive hematology event of the year for invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology.

The final program, personal scheduler, oral and poster sessions, scientific program, education program, general sessions, special-interest sessions, trainee activities, policy and practice, global capacity-building showcase, acknowledgments, related content

Meeting Abstracts

Schedule-at-a-Glance

Nov 7th, 2019 - As the adult hematology and oncology fellowship training pathways have merged in the United States and concerns have arisen about the aging of practicing hematologists, the American Society of Hematology and hematology education leaders are looking to improve their understanding of the factors that contribute to fellows' plans to enter hematology-only careers. With the support of the American S...

Nov 6th, 2019 - This report illustrates the importance of a detailed history and physical exam and careful analysis of hematologic parameters when diagnosing ITP. This case demonstrates that even with subtle deviations from typical ITP findings one must promptly reevaluate the diagnosis. This case also highlights the importance of peripheral smear review by an expert in pediatric hematopathology. A previously ...

Nov 1st, 2019 - Remembering Thomas P. Stossel (1941 – 2019) Thomas P. Stossel, MD, former president of the American Society of Hematology (ASH), passed away unexpectedly on September 29. Born in Chicago in 1941, Dr. Stossel grew up in Wilmette, Illinois. He attended Princeton University and Harvard Medical School before completing his internal medicine training at Massachusetts General Hospital and his hematol...

Nov 1st, 2019 - Jane N. Winter, MD, Vice President Alison Loren, MD, Councillor Bob Löwenberg, MD, PhD, Councillor Congratulations to ASH’s Three New Executive Committee Members The American Society of Hematology (ASH) has announced the election of three new members to its Executive Committee for terms beginning after the 2019 ASH Annual Meeting in December. Jane N. Winter, MD, will serve a one-year term as vi...

Oct 27th, 2019 - Standardized variant curation is essential for clinical care recommendations for patients with inherited disorders. Clinical Genome Resource (ClinGen) variant curation expert panels are developing disease-associated gene specifications using the 2015 American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) guidelines to reduce curation discrepancies...

Oct 24th, 2019 - Florida Cancer Specialists & Research Institute (FCS) welcomes Zanetta Lamar, MD, to the statewide practice. She is practicing medical oncology and hematology in the Naples Goodlette office. Zanetta Lamar, MD After earning her medical degree with honors from Meharry Medical College in Nashville, Dr. -Lamar completed her internal medicine internship and residency, as well as her hematology and o...

Oct 21st, 2019 - End-induction minimal residual disease (MRD) is the strongest predictor of relapse in paediatric acute lymphoblastic leukaemia (ALL), but an understanding of the biological pathways underlying early treatment response remains elusive. We hypothesized that metabolomic profiling of diagnostic bone marrow plasma could provide insights into the underlying biology of early treatment response and inf...

Oct 15th, 2019 - Guidelines Summary Guidelines for the diagnosis and management of pulmonary embolism (PE) have been issued by the following organizations: American Academy of Family Physicians (AAFP)/American College of Physicians (ACP) [4] American College of Physicians (ACP) [111] American College of Emergency Physicians (ACEP) [112] American College of Radiology (ACR) [69] American College of Chest Physicia...

Oct 14th, 2019 - Approach Considerations Diagnosis of venous thromboembolism (VTE) may include laboratory tests, imaging (eg, chest radiography, computed tomography [CT], angiography, ultrasonography [US], echocardiography, and ventilation-perfusion [V/Q] scanning) and tests such as plethysmography and electrocardiography (ECG). Guidelines for diagnosis of VTE have been published by the American Society of Hema...

Oct 14th, 2019 - The FDA approved rivaroxaban (Xarelto) to prevent venous thromboembolism (VTE) and related deaths for at-risk acutely ill medical patients not at high risk of bleeding, Janssen announced Monday. The approval was for the hospitalization and through discharge to a total recommended duration of 31 to 39 days. "Rather than facing daily injections with older anticoagulants, patients now have a new o...

Oct 11th, 2019 - In people with sickle cell disease, sickled red blood cells cause the occlusion of small blood vessels which presents as episodes of severe pain known as pain crises or vaso-occlusive crises. The pain can occur in the bones, chest, or other parts of the body, and may last several hours to days. Pain relief during crises includes both pharmacologic and non-pharmacologic treatments. The efficacy ...

Oct 9th, 2019 - Cancer and kidney disease are linked by causality and comorbidities. Observational data show an increased risk of malignancy as renal function declines. Erythropoietin stimulating agents (ESAs), which are the cornerstone therapy for anemia patients with chronic kidney disease and cancer, are associated with increased risks for cancer, cancer-related mortality, progression of disease, and thromb...

Oct 1st, 2019 - ASH Clinical News Now Available on the ASH Publications App The American Society of Hematology (ASH) Publications app provides access to content from Blood, Blood Advances, The Hematologist, and, now, ASH Clinical News, plus great features that allow readers to: Save articles for offline reading Take notes on specific articles Access Blood articles ahead of publication with First Edition Get no...

Oct 1st, 2019 - Stanley Schrier, MD Remembering Stanley Schrier (1929 – 2019) Stanley Schrier, MD, a former American Society of Hematology (ASH) president who spent nearly 60 years at Stanford University’s Department of Medicine, passed away on August 16. In 1954, Dr. Schrier graduated from Johns Hopkins University School of Medicine, where he remained for his internship before moving to the universities of Mi...

Sep 23rd, 2019 - Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting.|2019||therapeutic use,therapeutic use,therapeutic use,therapy,drug therapy,therapy,therapy,

Sep 23rd, 2019 - Highlights in chronic lymphocytic leukemia from the 60th American Society of Hematology Annual Meeting.|2019||adverse effects,therapeutic use,adverse effects,therapeutic use,adverse effects,therapeutic use,therapy,drug therapy,genetics,therapy,adverse effects,therapeutic use,adverse effects,therapeutic use,adverse effects,therapeutic use,